A method for synthesizing fluororemdesivir

A novel synthesis method for fluororemdesivir compounds through glycosylation, cyanation, and phosphorylation steps addresses inefficiencies in existing methods, offering a high-yield, streamlined process for nucleoside drug development.

CN117126199BActive Publication Date: 2024-12-06JIANGXI NORMAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310552338.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-05-17
Publication Date
2024-12-06
Estimated Expiration
2043-05-17

AI Technical Summary

Technical Problem

Existing methods for synthesizing fluororemdesivir compounds are lengthy, complex, and yield inefficient, hindering the development and production of nucleoside drugs.

Method used

A novel chemical synthesis method involving glycosylation, cyanation, debenzylation, and phosphorylation steps to produce 2-ethylbutyl((S)-(((2R,3R,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine and its stereoisomer, utilizing specific molar ratios and low-temperature reactions to achieve intermediates.

Benefits of technology

The method provides a short, efficient route with high yields (>55%) for synthesizing fluororemdesivir compounds, facilitating the modification and production of nucleoside drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117126199B_ABST
    Figure CN117126199B_ABST
Patent Text Reader

Abstract

The invention discloses a method for synthesizing fluorinated remdesivir. The method uses fluorinated pentasaccharide (2-deoxy-2-fluoro-3,5-di-O-benzyl-D-ribonucleic acid-γ-lactone or 2-deoxy-2-fluoro-3,5-di-O-benzyl-D-arabinofuranosononic acid-γ-lactone) as a starting material, and obtains 2-ethylbutyl ((S)-(((2R,3R,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuranose through four steps of sugar carbonylation, cyanation, removal of benzyl protecting group and phosphorylation. The invention discloses two generations of remdesivir, namely, 2-((S)-(((2R,3R,4S,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine; the synthetic method has a short route, simple steps and relatively high yield, and provides a new synthetic route for the synthesis or modification design of nucleoside drugs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a drug synthesis method, and in particular to a synthesis method of fluororemdesivir (2-ethylbutyl ((S)-(((2R,3R,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound or 2-ethylbutyl ((S)-(((2R,3R,4S,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound, belonging to the technical field of drug synthesis. Background Art

[0002] In 1950, 2-bromo-2-chloro-1,1,1-trifluoroethane was used as an inhaled anesthetic, indicating that fluorine has the potential to regulate bioactive molecules (Ostercamp DL, BR, Chemical Aspects of General Anesthesia: Part I. From Ether to Halothane 1. Journal of Chemical Education 2006, 83, 1821); in 1953, Josef Fried and Emily Sabo found that 9α-fludrocortisone (as shown in the reaction below) has an anti-inflammatory activity more than 10 times higher than that of cortisol, indicating that the introduction of fluorine atoms at designated positions on drug molecules can improve their drug properties (Sabo, JFaEF, 9-α-Fluoroderivatives of cortisone and hydrocortisone. J.Am.Chem.Soc.1954, 76, 1455); in 1957, Robert Duschinsky et al. synthesized the fluorine-containing drug 5-fluorouracil (as shown in the reaction). As an anti-tumor drug, it showed high anti-cancer activity by inhibiting thymidylate synthase, thereby preventing cells from synthesizing thymidine (C. Heidelberger, NKC, P. Danneberg, D. Mooren, L. Griesbach, R. Duschinsky and RJ Schnitzer, FLUORINATED PYRIMIDINES, A NEW CLASS OF TUMOUR-INHIBITORY COMPOUNDS. Nature 1957, 179, 663). The discovery of these two fluorine-containing drugs laid the foundation for the increasing role of fluorine in life sciences.

[0003] At the end of 2020, the general trend of the number of fluorine-containing drugs approved by the US Food and Drug Administration is increasing (Johnson, BM; Shu, YZ; Zhuo, X.; Meanwell, NA, Metabolic and Pharmaceutical Aspects of Fluorinated Compounds. J Med Chem 2020, 63, 6315-6386), (Yu, Y.; Liu, A.; Dhawan, G.; Mei, H.; Zhang, W.; Izawa, K.; Soloshonok, VA; Han, J., Fluorine-containing pharmaceuticals approved by the FDA in 2020: Synthesis and biological activity. Chinese Chemical Letters 2021). Due to the characteristics of fluorine, the introduction of fluorine into drug molecules can change their properties in many aspects, so fluorine is of great significance to the modification of nucleoside drugs.

[0004] Summary of the invention

[0005] In view of the defects of the prior art, the purpose of the present invention is to provide a chemical synthesis method of a fluoro-remdesivir compound, which has the characteristics of a short route, simple steps, and a relatively high yield, and provides a new approach for the synthesis or modification of nucleoside drugs.

[0006] In order to achieve the above technical objectives, the present invention provides a method for synthesizing a 2-ethylbutyl((S)-(((2R,3R,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound, the method comprising the following steps:

[0007] 1) 2-deoxy-2-fluoro-3,5-di-O-benzyl-D-ribonucleic acid-γ-lactone and 4-amino-7-bromopyrrolo[2,1-F][1,2,4]triazine are subjected to a glycosylation reaction to obtain intermediate 3;

[0008] 2) intermediate 3 is reacted with trifluoroacetic acid, trimethylsilyl trifluoromethanesulfonate and trimethylsilyl cyanide to obtain intermediate 4;

[0009] 3) intermediate 4 is subjected to a debenzylation reaction to obtain intermediate 5;

[0010] 4) phosphorylating the intermediate 5 with 2-ethylbutyl((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alanine to obtain a 2-ethylbutyl((S)-(((2R,3R,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound;

[0011] The structural formula of the 2-ethylbutyl((S)-(((2R,3R,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound is as follows:

[0012]

[0013] The structures of intermediates 3, 4, and 5 are as follows:

[0014]

[0015] As a preferred scheme, the process of the sugar carbonylation reaction is: 1,2-bis(chlorodimethylsilyl)ethane solution is mixed with 4-amino-7-bromopyrrolo[2,1-F][1,2,4]triazine solution, stirred for 5 to 20 minutes, then diisopropylamine is added, stirred for 3 to 10 minutes, then placed in a low temperature environment below -50°C, stirred for at least 20 minutes, then n-butyl lithium is slowly added dropwise, stirred for 15 to 60 minutes, then 2-deoxy-2-fluoro-3,5-di-O-benzyl-D-ribonucleic acid-γ-lactone solution is added dropwise, stirred for 1 to 5 hours, then citric acid solution is added, the temperature is raised to 0 to 5°C, and stirred for 10 to 30 minutes. More specific reaction process: at room temperature, after replacing the gas (using inert gas to replace air), add the tetrahydrofuran solution of 1,2-bis(chlorodimethylsilyl)ethane to the tetrahydrofuran solution of 4-amino-7-bromopyrrolo[2,1-F][1,2,4]triazine and stir for 5 to 20 minutes; then add diisopropylamine and stir for 3 to 10 minutes; place in a -78°C low-temperature constant temperature stirrer to cool, stir for at least 20 minutes, then slowly add n-butyl lithium and stir for 15 to 60 minutes; then dissolve 2-deoxy-2-fluoro-3,5-di-O-benzyl-D-ribono-γ-lactone in tetrahydrofuran, add dropwise to the system, stir for 1 to 5 hours, add 1M citric acid solution, heat to 0°C, and stir for 10 to 30 minutes. Among them, the molar ratio of 1,2-bis(chlorodimethylsilyl)ethane:4-amino-7-bromopyrrolo[2,1-F][1,2,4]triazine:diisopropylamine:2-deoxy-2-fluoro-3,5-di-O-benzyl-D-arabinofuranoic acid-γ-lactone is 0.5-1.5:1.0:0.5-1.5:1.0-3.0.

[0016] As a preferred solution, the process of the cyanation reaction is: dissolve the intermediate 3 in a solvent, place it in a low temperature environment below -50°C, stir for at least 20 minutes, then add trifluoroacetic acid, stir for 5 to 30 minutes, then drop trimethylsilyl trifluoromethanesulfonate, stir for 10 to 60 minutes, then add trimethylsilyl cyanide, and stir for 1 to 5 hours. A more specific reaction process: after replacing the gas, dissolve the intermediate 3 in dichloromethane, place it in a -78°C low-temperature constant temperature stirrer to cool, stir for at least 20 minutes, then add trifluoroacetic acid, stir for 5 to 30 minutes, drop trimethylsilyl trifluoromethanesulfonate, stir for 10 to 60 minutes, then add trimethylsilyl cyanide, and stir for 1 to 5 hours. Molar ratio of intermediate 3: trifluoroacetic acid: trimethylsilyl trifluoromethanesulfonate: trimethylsilyl cyanide = 1.0: 1.0 to 5.0: 1.0 to 10.0: 1.0 to 10.0.

[0017] As a preferred scheme, the process of the debenzylation reaction is: dissolve the intermediate 4 in a solvent, place it in a low temperature environment below -50°C, stir for at least 20 minutes, then drop boron trichloride, raise the temperature to -40 to -30°C, and stir for 1 to 5 hours. More specifically, after replacing the gas, dissolve the intermediate 4 in dichloromethane, place it in a low-temperature thermostatic stirrer at -78°C to cool, stir for at least 20 minutes, then drop boron trichloride, raise the temperature to -40°C, and stir for 1 to 5 hours. Wherein, the molar ratio of intermediate 4: boron trichloride = 1.0: 1.0 to 10.0.

[0018] As a preferred solution, the phosphorylation reaction process is as follows: the intermediate 5 is dissolved in a solvent and 2-ethylbutyl((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alanine is dissolved in a solvent, and the mixture is placed in an ice bath environment, dimethylaluminum chloride is slowly added dropwise, and the mixture is heated to room temperature and stirred for 5 to 10 days. A more specific reaction process is as follows: gas replacement, the intermediate 5 and 2-ethylbutyl((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alanine are dissolved in an ice bath environment, dimethylaluminum chloride is slowly added dropwise, and the mixture is heated to room temperature and stirred for 5 to 10 days.

[0019] The present invention also provides a method for synthesizing a 2-ethylbutyl((S)-(((2R,3R,4S,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound, which comprises the following steps:

[0020] 1) 2-deoxy-2-fluoro-3,5-di-O-benzyl-D-arabinofuranoic acid-γ-lactone and 4-amino-7-bromopyrrolo[2,1-F][1,2,4]triazine are subjected to a glycosylation reaction to obtain intermediate 9;

[0021] 2) intermediate 9 is reacted with trifluoroacetic acid, trimethylsilyl trifluoromethanesulfonate and trimethylsilyl cyanide to obtain intermediate 4 or intermediate 10;

[0022] 3) intermediate 10 is subjected to a benzyl protecting group removal reaction to obtain intermediate 5 or intermediate 11;

[0023] 4) phosphorylating the intermediate 11 with 2-ethylbutyl((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alanine to obtain a 2-ethylbutyl((S)-(((2R,3R,4S,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound;

[0024] in,

[0025] The structural formula of the 2-ethylbutyl((S)-(((2R,3R,4S,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound is as follows:

[0026]

[0027] The structures of intermediates 9, 10, and 11 are as follows:

[0028]

[0029] As a preferred scheme, the process of the sugar carbonylation reaction is: 1,2-bis(chlorodimethylsilyl)ethane solution is mixed with 4-amino-7-bromopyrrolo[2,1-F][1,2,4]triazine solution, stirred for 5 to 20 minutes, then diisopropylamine is added, stirred for 3 to 10 minutes, then placed in a low temperature environment below -50°C, stirred for at least 20 minutes, then n-butyl lithium is slowly added dropwise, stirred for 15 to 60 minutes, then 2-deoxy-2-fluoro-3,5-di-O-benzyl-D-arabinofuranosonic acid-γ-lactone solution is added dropwise, stirred for 1 to 5 hours, then citric acid solution is added, the temperature is raised to 0 to 5°C, and stirred for 10 to 30 minutes. More specific reaction process: at room temperature, after replacing the gas (using inert gas to replace air), add the tetrahydrofuran solution of 1,2-bis(chlorodimethylsilyl)ethane to the tetrahydrofuran solution of 4-amino-7-bromopyrrolo[2,1-F][1,2,4]triazine and stir for 5 to 20 minutes; then add diisopropylamine and stir for 3 to 10 minutes; place in a -78°C low-temperature constant temperature stirrer to cool, stir for at least 20 minutes, then slowly add n-butyl lithium and stir for 15 to 60 minutes; then dissolve 2-deoxy-2-fluoro-3,5-di-O-benzyl-D-arabinofuranoic acid-γ-lactone in tetrahydrofuran, add dropwise to the system, stir for 1 to 5 hours, add 1M citric acid solution, heat to 0°C, and stir for 10 to 30 minutes. Among them, the molar ratio of 1,2-bis(chlorodimethylsilyl)ethane:4-amino-7-bromopyrrolo[2,1-F][1,2,4]triazine:diisopropylamine:2-deoxy-2-fluoro-3,5-di-O-benzyl-D-arabinofuranoic acid-γ-lactone is 0.5-1.5:1.0:0.5-1.5:1.0-3.0.

[0030] As a preferred solution, the process of the cyanation reaction is: dissolve the intermediate 9 in a solvent, place it in a low temperature environment below -50°C, stir for at least 20 minutes, then add trifluoroacetic acid, stir for 5 to 30 minutes, then drop trimethylsilyl trifluoromethanesulfonate, stir for 10 to 60 minutes, then add trimethylsilyl cyanide, and stir for 1 to 5 hours. A more specific reaction process: after replacing the gas, dissolve the intermediate 9 in dichloromethane, place it in a -78°C low temperature constant temperature stirrer to cool, stir for at least 20 minutes, then add trifluoroacetic acid, stir for 5 to 30 minutes, drop trimethylsilyl trifluoromethanesulfonate, stir for 10 to 60 minutes, then add trimethylsilyl cyanide, and stir for 1 to 5 hours. Molar ratio of intermediate 9: trifluoroacetic acid: trimethylsilyl trifluoromethanesulfonate: trimethylsilyl cyanide = 1.0: 1.0 to 5.0: 1.0 to 10.0: 1.0 to 10.0.

[0031] As a preferred solution, the process of the debenzylation reaction is as follows: the intermediate 10 is dissolved in a solvent, placed in a low temperature environment below -50°C, stirred for at least 20 minutes, then boron trichloride is added dropwise, and the temperature is raised to -40 to -30°C, and stirred for 1 to 5 hours. A more specific reaction process is as follows: after replacing the gas, the intermediate 10 is dissolved in dichloromethane, placed in a low temperature constant temperature stirrer at -78°C to cool, stirred for at least 20 minutes, then boron trichloride is added dropwise, the temperature is raised to -40°C, and stirred for 1 to 5 hours. Wherein, the molar ratio of intermediate 10: boron trichloride = 1.0: 1.0 to 10.0.

[0032] As a preferred scheme, the phosphorylation reaction process is: the intermediate 11 is dissolved in a solvent and 2-ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alanine is dissolved in a solvent, and placed in an ice bath environment, dimethylaluminum chloride is slowly added dropwise, and the temperature is heated to room temperature and stirred for 5 to 10 days. A more specific reaction process is: after replacing the gas, the intermediate 11 and 2-ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alanine are dissolved in propane and butyric acid, dimethylaluminum chloride is slowly added dropwise under ice bath conditions, and the temperature is heated to room temperature and stirred for 5 to 10 days.

[0033] The synthetic reaction route of the 2-ethylbutyl ((S)-(((2R,3R,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound of the present invention is as follows:

[0034]

[0035] The specific reaction steps are as follows:

[0036] (1) At room temperature, replace the gas, add the tetrahydrofuran solution of 1,2-bis(chlorodimethylsilyl)ethane to the tetrahydrofuran solution of 4-amino-7-bromopyrrolo[2,1-F][1,2,4]triazine (Compound 2), and stir for 10 minutes; add diisopropylamine and stir for 5 minutes; place in a -78°C low-temperature constant temperature stirrer to cool, stir for at least 20 minutes, slowly drop n-butyl lithium and stir for 30 minutes; add 2-deoxy-2-fluoro-3,5-di-O -Benzyl-D-ribonucleic acid-γ-lactone (Compound 1) was dissolved in tetrahydrofuran, added dropwise to the system, and stirred for 2 hours; 1M citric acid solution was added, the temperature was raised to 0°C, and stirred for 20 minutes; the organic phase was separated, concentrated under reduced pressure to obtain a crude product intermediate 3, and further purified by column chromatography to obtain intermediate 3; wherein the molar ratio of 1,2-bis(chlorodimethylsilyl)ethane: Compound 2: diisopropylamine: Compound 1 = 0.5-1.5: 1.0: 0.5-1.5: 1.0-3.0;

[0037] (2) Replace the gas, dissolve the intermediate 3 in dichloromethane, place in a -78°C low-temperature constant temperature stirrer to cool, stir for at least 20 minutes, add trifluoroacetic acid, stir for 10 minutes, dropwise add trimethylsilyl trifluoromethanesulfonate, stir for 30 minutes, add trimethylsilyl cyanide, and stir for 2 hours. Quench the reaction, warm to room temperature, separate the organic phase, concentrate under reduced pressure, and perform silica gel column chromatography to obtain intermediate 4, wherein the molar ratio of intermediate 3: trifluoroacetic acid: trimethylsilyl trifluoromethanesulfonate: trimethylsilyl cyanide = 1.0: 1.0-5.0: 1.0-10.0: 1.0-10.0;

[0038] (3) Replace the gas, dissolve the intermediate 4 in dichloromethane, place in a -78°C low-temperature constant temperature stirrer to cool, stir for at least 20 minutes, drop boron trichloride, raise the temperature to -40°C, stir for 2 hours, cool to -78°C, drop dry methanol; dissolve dry triethylamine in dry methanol, and then drop it into the reaction system, after the dropwise addition is complete, raise the temperature to room temperature, concentrate under reduced pressure, and perform silica gel column chromatography to obtain intermediate 5, wherein the molar ratio of intermediate 4:boron trichloride = 1.0:1.0-10.0;

[0039] (4) Displacing the gas, the intermediate 5 and the photochemically pure compound 2-ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alanine (Compound 6) were dissolved in pyridine, and dimethylaluminum chloride was slowly added dropwise under ice bath conditions. The temperature was raised to room temperature and stirred for 7 days. A 30% L-tartaric acid solution was added to quench the reaction, and ethyl acetate was added to dilute. The organic phase was separated, concentrated under reduced pressure, and silica gel column chromatography was performed to obtain Compound 7; wherein the molar ratio of intermediate 5: Compound 6: dimethylaluminum chloride = 1.0: 1.0-5.0: 0.1-1.0.

[0040] The synthetic reaction route of the 2-ethylbutyl((S)-(((2R,3R,4S,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound of the present invention is as follows:

[0041]

[0042] The specific reaction steps are as follows:

[0043] (1) At room temperature, replace the gas, add the tetrahydrofuran solution of 1,2-bis(chlorodimethylsilyl)ethane to the tetrahydrofuran solution of 4-amino-7-bromopyrrolo[2,1-F][1,2,4]triazine (Compound 2), and stir for 10 minutes; add diisopropylamine and stir for 5 minutes; place in a -78°C low-temperature constant temperature stirrer to cool, stir for at least 20 minutes, slowly drop n-butyl lithium and stir for 30 minutes; add 2-deoxy-2-fluoro-3,5-di-O-benzyl Dissolve 1,2-dimethyl-D-arabinofuranosonic acid-γ-lactone (Compound 8) in tetrahydrofuran, add dropwise to the system, and stir for 2 hours; add 1M citric acid solution, heat to 0°C, and stir for 20 minutes; separate the organic phase, concentrate under reduced pressure to obtain a crude intermediate 9, and further purify by column chromatography to obtain intermediate 9; wherein the molar ratio of 1,2-bis(chlorodimethylsilyl)ethane: Compound 2: diisopropylamine: Compound 8 = 0.5-1.5: 1.0: 0.5-1.5: 1.0-3.0;

[0044] (2) Replace the gas, dissolve the intermediate 9 in dichloromethane, place in a -78°C low-temperature constant temperature stirrer to cool, stir for at least 20 minutes, add trifluoroacetic acid, stir for 10 minutes, dropwise add trimethylsilyl trifluoromethanesulfonate, stir for 30 minutes, add trimethylsilyl cyanide, and stir for 2 hours. Quench the reaction, warm to room temperature, separate the organic phase, concentrate under reduced pressure, and perform silica gel column chromatography to obtain the intermediate 10, wherein the molar ratio of intermediate 9: trifluoroacetic acid: trimethylsilyl trifluoromethanesulfonate: trimethylsilyl cyanide = 1.0: 1.0-5.0: 1.0-10.0: 1.0-10.0;

[0045] (3) replacing the gas, dissolving the intermediate 10 in dichloromethane, placing in a -78°C low-temperature constant temperature stirrer to cool, stirring for at least 20 minutes, adding boron trichloride dropwise, raising the temperature to -40°C, stirring for 2 hours, lowering the temperature to -78°C, and adding dry methanol dropwise; dissolving dry triethylamine in dry methanol, and then dropping it into the reaction system, after the dropping is complete, raising the temperature to room temperature, concentrating under reduced pressure, and performing silica gel column chromatography to obtain the intermediate 11, wherein the molar ratio of intermediate 10:boron trichloride = 1.0:1.0-10.0;

[0046] (4) Displacing the gas, the intermediate 11 and the photochemically pure compound 2-ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alanine (Compound 6) were dissolved in pyridine, and dimethylaluminum chloride was slowly added dropwise under ice bath conditions. The temperature was raised to room temperature and stirred for 7 days. A 30% L-tartaric acid solution was added to quench the reaction, and ethyl acetate was added to dilute the reaction. The organic phase was separated, concentrated under reduced pressure, and silica gel column chromatography was performed to obtain Compound 12; wherein the molar ratio of intermediate 11: Compound 6: dimethylaluminum chloride = 1.0: 1.0-5.0: 0.1-1.0.

[0047] Compared with the prior art, the technical solution of the present invention has the following beneficial technical effects:

[0048] The present invention successfully synthesizes two fluoro-remdesivir drugs, 2-ethylbutyl((S)-(((2R,3R,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine and 2-ethylbutyl((S)-(((2R,3R,4S,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine, by a chemical method, providing a new approach to the modification and design of nucleoside drugs.

[0049] The synthetic method of the present invention has a short route, simple steps and operations, and a relatively high yield (the yield of each step reaction is more than 55), which is conducive to achieving expanded production. BRIEF DESCRIPTION OF THE DRAWINGS

[0050] Figure 1 2-ethylbutyl((S)-(((2R,3R,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound 1 H NMR (400MHz,methanol-d 4 ,25℃).

[0051] Figure 2 2-ethylbutyl((S)-(((2R,3R,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound 19 F NMR (376MHz,methanol-d 4,25℃).

[0052] Figure 3 2-ethylbutyl((S)-(((2R,3R,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound 19 F NMR (376MHz,methanol-d 4 ,25℃).

[0053] Figure 4 2-ethylbutyl((S)-(((2R,3R,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound 31 P NMR (162MHz,methanol-d 4 ,25℃).

[0054] Figure 5 2-ethylbutyl((S)-(((2R,3R,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound 31 P NMR (162MHz,methanol-d 4 ,25℃).

[0055] Figure 6 2-ethylbutyl((S)-(((2R,3R,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound 13 C NMR (100MHz,methanol-d 4 ,25℃). DETAILED DESCRIPTION

[0056] The following specific examples are intended to further illustrate the present invention rather than to limit the scope of protection of the claims.

[0057] Unless otherwise specified, the chemical reagents involved in the following examples are conventional commercially available analytically pure reagents.

[0058] Example 1

[0059] (1) Synthesis of intermediate 3

[0060] 4-Amino-7-bromopyrrolo[2,1-F][1,2,4]triazine (Compound 2) (321 mg, 1.515 mmol) was weighed in a dry 50 mL round-bottom flask, the gas was replaced three times, tetrahydrofuran (25.8 mL) was added, and the mixture was stirred at room temperature for 5 min. 1,2-Bis(chlorodimethylsilyl)ethane (358.7 mg, 1.667 mmol) was weighed in a dry 5 mL round-bottom flask, dry tetrahydrofuran (1.6 mL) was added to dissolve it and added to the reaction system, and the mixture was stirred at room temperature for 10 min. Diisopropylamine (234 μL, 1.667 mmol) was added, and the mixture was stirred at room temperature for 5 min. The mixture was placed in a -78°C low-temperature thermostatic stirrer to cool, stirred for at least 20 min, and n-butyllithium (1.6 M in ) was slowly added. n-hexane, 4.07 mL, 6.515 mmol), stirred for 30 min; 2-deoxy-2-fluoro-3,5-di-O-benzyl-D-ribono-γ-lactone (Compound 1) (1.0 g, 3.029 mmol) was weighed in a dry 5 mL round-bottom flask, tetrahydrofuran (1.6 mL) was added to dissolve, and then added dropwise to the system, stirred for 2 h, and the reaction was monitored by TLC.

[0061] After monitoring the completion of the reaction, 1M citric acid solution (16 mL) was added to quench the reaction, the temperature was raised to 0°C, the organic phase was separated, and the crude product was concentrated under reduced pressure. The crude product was dissolved, silica gel was added to mix the sample, and silica gel column chromatography was performed to obtain intermediate 3 (421 mg, 60%, petroleum ether: ethyl acetate = 1:2, R f =0.25).

[0062] (2) Synthesis of intermediate 4

[0063] Intermediate 3 (421 mg, 0.907 mmol) was weighed in a 25 mL reaction bottle, the gas was replaced three times, dichloromethane (12 mL) was added, stirred to dissolve, placed in a -78 ° C low temperature constant temperature stirrer to cool, stirred for at least 20 min, trifluoroacetic acid (208 μL, 2.721 mmol) was added, stirred for 10 min, trimethylsilyl trifluoromethanesulfonate (0.98 mL, 5.442 mmol) was added dropwise, stirred for 30 min, trimethylsilyl cyanide (0.68 mL, 5.442 mmol) was added, stirred for 2 h, and the reaction was monitored by TLC.

[0064] Monitor the reaction completion, quench the reaction, warm to room temperature, separate the organic phase, concentrate under reduced pressure, mix the sample, and perform silica gel column chromatography to obtain intermediate 4 (259 mg, 60%, petroleum ether: ethyl acetate = 1:2, R f =0.7).

[0065] (3) Synthesis of Intermediate 5

[0066] Intermediate 4 (231 mg, 0.488 mmol) was weighed in a 25 mL bottle, the gas was replaced three times, dichloromethane (2.7 mL) was added, stirred to dissolve, placed in a -78 °C low-temperature constant temperature stirrer to cool, stirred for at least 20 min, boron trichloride (1 Min methylene chloride, 3.71 mL, 3.71 mmol) was added dropwise, the temperature was raised to -40 °C, stirred for 2 h, and the reaction was monitored by TLC.

[0067] After monitoring the completion of the reaction, the temperature was lowered to -78°C, and dry methanol (1.08 mL) was added dropwise; dry triethylamine (1.4 mL) was dissolved in dry methanol (2.2 mL), and then added dropwise to the reaction system. After the addition was completed, the temperature was raised to room temperature, concentrated under reduced pressure, dissolved with methanol, silica gel was added to mix the sample, and ethyl acetate was used for silica gel column chromatography to obtain the product 1-cyano-1-C-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-2-deoxy-2-fluoro-D-ribose intermediate 5 (137 mg, 96%, petroleum ether:ethyl acetate=1:4, R f =0.2).

[0068] [α] D 25 =-51.1(c 1.0,C 2 H 5 OH); mp: 166-169°C;

[0069] 1 H-NMR (400MHz,methanol-d 4 ): δ7.89(s,1H),7.00(d,J=4.8Hz,1H),6.90(d,J=4.8Hz,1H),5.47(dd,J=53.8,4.0Hz,1H), 4.68(s,2H),4.30-4.21(m,2H),3.95(dd,J=12.6,2.0Hz,1H),3.75(dd,J=12.6,4.0Hz,1H);

[0070] 13 C-NMR (100MHz,methanol-d 4 ): δ157.20,148.53,123.67(d,J=5.0Hz,1C),118.15,116.18(d,J=7.2Hz,1C),112.47,102.7 5,93.69(d,J=200.4Hz,1C),85.06,79.09(d,J=20.5Hz,1C),70.52(d,J=16.7Hz,1C),61.76;

[0071] 19 F NMR (376MHz,methanol-d 4 ):δ-197.79--197.98(m,1F);

[0072] 19 F NMR (376MHz,methanol-d 4 ):δ-197.88(s,1F);

[0073] HRMS(ESI)m / z calcd for C 12 H 12 FN 5 O 3 Na + (M+Na) + 316.0816, found 316.0816.

[0074] (4) Synthesis of Compound 7

[0075] Intermediate 5 (50 mg, 0.171 mmol) and photochemically pure compound 2-ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alanine (Compound 6) (169 mg, 0.341 mmol) were added to a 10 mL round-bottom flask, the gas was replaced three times, dry pyridine (1.7 mL) was added, the temperature was lowered and stirred in an ice bath for 10 min, dimethylaluminum chloride (1 M in heptane, 86 μL, 0.086 mmol) was slowly added dropwise, the temperature was raised to room temperature and stirred for 7 d, and the reaction was monitored by TLC.

[0076] The reaction was monitored to completion, 30% L-tartaric acid solution (1 mL) was added to quench the reaction, ethyl acetate was added to dilute, the organic phase was separated, concentrated under reduced pressure, and the sample was mixed. Silica gel column chromatography gave compound 7 (66 mg, 64%, petroleum ether: ethyl acetate = 1:4, R f =0.4).

[0077] 1 H NMR (400MHz,methanol-d 4 ): δ7.89(s,1H),7.35-7.30(m,2H),7.24-7.16(m,3H),5.48(dd,J=53.4,4.1Hz,1H),4.51-4.46(m,1H),4.39 -4.23(m,3H),4.04-4.00(m,1H),3.95-3.91(m,2H),1.48-1.42(m,1H),1.34-1.27(m,8H),0.87-0.83(m,6H);

[0078] 19 F NMR (376MHz,methanol-d 4 ):δ-196.98--197.18(m,1F);

[0079] 19 F NMR (376MHz,methanol-d 4 ):δ-197.08(s,1F);

[0080] 31 PNMR (162MHz,methanol-d 4 ):δ3.68-3.54(m,1P);

[0081] 31 PNMR (162MHz,methanol-d 4 ):δ3.61(s,1P);

[0082] 13 C NMR (100MHz,methanol-d 4 ): δ174.99,174.94,157.17,152.16,125.10,148.59,130.76,126.13,123.31,123.26,121.35,121.31,118.21,115.78,115.70,112.33, 102.77,94.62,92.63,82.39,82.31,79.41,79.20,70.57,70.40,68.09,66.27,66.22,51.50,41.67,24.19,20.61,20.54,11.33,11.28;

[0083] HRMS(ESI)m / z calcd for C 27 H 34 FN 6 O 7 PNa + (M+Na) + 627.2103, found 627.2107.

[0084] Example 2

[0085] (1) Synthesis of Intermediate 9

[0086] Referring to AU, Patent 2015238851A1, reaction condition 4 was used. Although the yield was low, only 20%, the target product was obtained, which provided a control point for the screening point plate of the subsequent reaction conditions. In reaction condition 5, NaH was added, and the yield was increased to 41%. When the feed was amplified 10 times, the yield was reduced to 34%. Reaction condition 7, the yield was only 42% at the beginning. Later, the reaction solvent was increased, the concentration of the reaction system was reduced, and reaction condition 8 was used, and the yield reached 68%. This condition was amplified 10 times, and the yield did not change significantly. Therefore, the best reaction condition for the connection of non-natural bases to the ribose center is condition 8. As shown in the following table:

[0087]

[0088] The following is a specific implementation plan: 4-amino-7-bromopyrrolo[2,1-F][1,2,4]triazine (Compound 2) (433.4 mg, 2.0446 mmol) was weighed in a dry 50 mL round-bottom flask, the gas was replaced three times, dry tetrahydrofuran (20 mL) was added under nitrogen protection, and stirred at room temperature for 5 min; 1,2-bis(chlorodimethylsilyl)ethane (484.2 mg, 2.249 mmol) was weighed in a dry 5 mL round-bottom flask, dry tetrahydrofuran (3 mL) was added to dissolve it and added to the reaction system, stirred at room temperature for 10 min, diisopropylamine (0.32 mL, 2.249 mmol) was added, stirred at room temperature for 5 min, placed in a -78 ° C low-temperature constant temperature stirrer to cool, stirred for at least 20 min, and n-butyl lithium (1.6 M in ) was slowly added dropwise. n-hexane, 5.5 mL, 8.792 mmol), after completion of the addition, stir at -78 ° C for 30 min; 2-deoxy-2-fluoro-3,5-di-O-benzyl-D-arabinofuranoic acid-γ-lactone (Compound 8) (1.35 g, 4.0893 mmol) was weighed in a dry 5 mL round-bottom flask, dry tetrahydrofuran (3 mL) was added to dissolve it and slowly added dropwise to the reaction system. After completion of the addition, stir at -78 ° C for 2 h, monitor the reaction by TLC, and use petroleum ether: ethyl acetate = 1:2 for climbing the plate.

[0089] The reaction was monitored to completion, 1 M citric acid solution (16 mL) was added to quench the reaction, the temperature was raised to 0°C, the organic phase was separated, and the crude product was concentrated under reduced pressure. The crude product was dissolved, silica gel was added to mix the sample, and silica gel column chromatography was performed to obtain intermediate 9 (542 mg, 68%, petroleum ether: ethyl acetate = 1:2, R f =0.25).

[0090] (2) Synthesis of Intermediate 10

[0091] 1-C-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-2-deoxy-2-fluoro-3,5-di-O-benzyl-D-ribose (Intermediate 4) was subjected to cyanation reaction. When the reaction temperature was initially controlled at -78°C, solids precipitated during the reaction. The reaction was carried out according to the reaction operation. The plate was found to have unreacted raw materials. The yield was 60% (reaction condition 1). 1-C-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-2-deoxy-2-fluoro-3,5-di-O-benzyl-D-arabinofuranosyl (Intermediate 9) was used to try the reaction again. The experimental phenomenon was the same, and the yield was 65% (reaction condition 2, upper half). The reason why the raw materials were not completely reacted was analyzed. Because the equivalent ratio of the feed in the cyanation reaction in the synthesis of Remdesivir can react the raw materials completely, combined with the appearance of solids during the reaction, it was realized that the raw materials could not be well dissolved in the solvent at -78°C, so temperature-raising measures were taken. 1-C-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-2-deoxy-2-fluoro-3,5-di-O-benzyl-D-arabinofuranosyl (intermediate 9) was used as the reaction substrate, and the reaction temperature was slowly raised from -78°C to observe the dissolution of the solid until -40°C, the solution was clear, trifluoroacetic acid was added and stirred for a while, then trimethylsilyl trifluoromethanesulfonate and trimethylsilyl cyanide were added, and the plate was stirred for 2h. It was found that the raw materials reacted completely, and the yield was 83% (reaction condition 2, the second half). Next, the temperature of the cyanation reaction was controlled at -40°C, and the specific contents are shown in the following table:

[0092]

[0093] The following is a specific implementation plan: intermediate 9 (50 mg, 0.108 mmol) was weighed in a dry 10 mL round-bottom flask, the gas was replaced three times, dry dichloromethane (1.4 mL) was added under nitrogen protection, stirred to dissolve, placed in a -78 ° C low-temperature constant temperature stirrer to cool, stirred for at least 20 min, trifluoroacetic acid (24 μL, 0.323 mmol) was added, stirred for 10 min, trimethylsilyl trifluoromethanesulfonate (117 μL, 0.648 mmol) was added dropwise, stirred for 30 min, trimethylsilyl cyanide (81 μL, 0.648 mmol) was added, stirred for 2 h, the reaction was monitored by TLC, and petroleum ether: ethyl acetate = 1:2 was used for climbing the plate.

[0094] Monitor the reaction completion, quench the reaction, warm to room temperature, separate the organic phase, concentrate under reduced pressure, mix the sample, and perform silica gel column chromatography to obtain intermediate 10 (33 mg, 65%, petroleum ether: ethyl acetate = 1:2, R f =0.7).

[0095] (3) Synthesis of intermediate 11

[0096] Intermediate 10 (189 mg, 0.399 mmol) was weighed in a dry 25 mL round-bottom flask, and the gas was replaced three times. Under nitrogen protection, dry dichloromethane (2.2 mL) was added and stirred to dissolve. The mixture was placed in a -78 °C low-temperature constant temperature stirrer for cooling and stirred for at least 20 min. Boron trichloride (1 M in methylene chloride, 3.04 mL, 3.04 mmol) was added dropwise. After the addition was complete, the mixture was heated to -40 °C and stirred for 2 h. The reaction was monitored by TLC using a plate containing petroleum ether: ethyl acetate = 1:1.

[0097] After monitoring the completion of the reaction, the temperature was lowered to -78°C, and dry methanol (0.88 mL) was added dropwise; dry triethylamine (1.44 mL) was dissolved in dry methanol (1.76 mL), and then added dropwise to the reaction system. After the addition was completed, the temperature was raised to room temperature, concentrated under reduced pressure, dissolved in methanol, silica gel was added to mix the sample, and ethyl acetate was used for silica gel column chromatography to obtain intermediate 11 (105 mg, 90%, petroleum ether: ethyl acetate = 1:4, R f =0.2).

[0098] 1 HNMR (400MHz,methanol-d 4 ): δ7.88(s,1H),6.91-6.88(m,2H),5.67(d,J=49.6,Hz,1H),4.42-4.31(m,2H),3.83-3.75(m,2H);

[0099] 13 C-NMR (100MHz,methanol-d 4 ): δ157.03,148.27,122.99,116.98,116.88,116.79,111.64,102.73,100.57(d, J=198.8Hz,1C),88.61,79.47(d,J=31.3Hz,1C),77.07(d,J=26.82Hz,1C),62.44;

[0100] 19 F NMR (376MHz,methanol-d 4 ):δ-186.37--186.55(m,1F);

[0101] 19 F NMR (376MHz,methanol-d 4 ):δ-186.46(s,1F);

[0102] HRMS(ESI)m / z calcd for C12 H 12 FN 5 O 3 Na + (M+Na) + 316.0816, found 316.0818.

[0103] (4) Synthesis of Compound 12

[0104] Intermediate 11 (50 mg, 0.171 mmol) and photochemically pure compound 2-ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alanine (Compound 6) (169 mg, 0.341 mmol) were added to a 10 mL round-bottom flask, the gas was replaced three times, dry pyridine (1.7 mL) was added, the temperature was lowered and stirred in an ice bath for 10 min, dimethylaluminum chloride (1 M in heptane, 86 μL, 0.086 mmol) was slowly added dropwise, the temperature was raised to room temperature and stirred for 7 d, and the reaction was monitored by TLC.

[0105] The reaction was monitored to completion, 30% L-tartaric acid solution (1 mL) was added to quench the reaction, ethyl acetate was added to dilute, the organic phase was separated, concentrated under reduced pressure, and the sample was mixed. Silica gel column chromatography gave compound 12 (58.8 mg, 57%, petroleum ether: ethyl acetate = 1:4, R f =0.4)

[0106] 1 H NMR (400MHz,methanol-d 4 ): δ7.89(s,1H),7.36-7.16(m,5H),6.90(d,J=4.6Hz,1H),6.82(d,J=4.6Hz,1H),5.69(d,J=49.14Hz ,1H),4.50-4.27(m,4H),4.05-3.94(m,3H),1.50-1.42(m,1H),1.36-1.29(m,8H),0.88-0.84(m,6H);

[0107] 19 F NMR (376MHz,methanol-d 4 ):δ-186.37--186.55(m,1F);

[0108] 19 F NMR (376MHz,methanol-d 4 ):δ-186.46(s,1F);

[0109] 31 PNMR (162MHz,methanol-d4 ):δ3.50-3.35(m,1P);

[0110] 31 PNMR (162MHz,methanol-d 4 ):δ3.43(s,1P);

[0111] 13 C NMR (100MHz,methanol-d 4 ): δ174.96,174.92,158.85,157.03,152.21,152.14,148.40,130.79,126.13,121.42,124.37,116.58,116.50,11 1.67,102.76,101.14,99.18,86.47,79.51,76.79,68.11,66.46,51.54,41.66,24.21,20.61,20.54,11.34,11.29;

[0112] HRMS(ESI)m / z calcd for C 27 H 34 FN 6 O 7 PNa + (M+Na) + 627.2103, found 627.2107.

[0113] The above is only a preferred embodiment of the present invention. The present invention is not limited to the above implementation. As long as the technical effect of the present invention is achieved by the same means, it should belong to the protection scope of the present invention. Within the protection scope of the present invention, its technical scheme and / or implementation method can have various modifications and changes.

Claims

1. A method for synthesizing a 2-ethylbutyl((S)-(((2R,3R,4S,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound, characterized in that: The following steps are involved: 1) 2-deoxy-2-fluoro-3,5-di-O-benzyl-D-arabinofuranoic acid-γ-lactone and 4-amino-7-bromopyrrolo[2,1-F][1,2,4]triazine are subjected to a glycosylation reaction to obtain intermediate 9; 2) intermediate 9 is reacted with trifluoroacetic acid, trimethylsilyl trifluoromethanesulfonate and trimethylsilyl cyanide to obtain intermediate 10; 3) intermediate 10 is subjected to a benzyl protecting group removal reaction to obtain intermediate 11; 4) phosphorylating the intermediate 11 with 2-ethylbutyl((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alanine to obtain a 2-ethylbutyl((S)-(((2R,3R,4S,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound; The structural formula of the 2-ethylbutyl((S)-(((2R,3R,4S,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound is as follows: The structures of intermediates 9, 10, and 11 are as follows: 、 、 ; The process of the sugar carbonylation reaction is as follows: 2.0446mmol 4-amino-7-bromopyrrolo[2,1-F][1,2,4]triazine is weighed in a dry 50mL round-bottom flask, the gas is replaced three times, 20mL dry tetrahydrofuran is added under nitrogen protection, and the mixture is stirred at room temperature for 5min; 2.249mmol 1,2-bis(chlorodimethylsilyl)ethane is weighed in a dry 5mL round-bottom flask, 3mL dry tetrahydrofuran is added to dissolve the mixture and the mixture is added to the reaction system, the mixture is stirred at room temperature for 10min, 2.249mmol diisopropylamine is added, the mixture is stirred at room temperature for 5min, the mixture is placed in a -78°C low-temperature thermostatic stirrer for cooling, the mixture is stirred for at least 20min, 8.792mmol n-butyllithium is slowly added dropwise, and after the addition is completed, the mixture is stirred at -78°C for 30min; 4.0893mmol 2-deoxy-2-fluoro-3,5-di-O-benzyl-D-arabinofuranoic acid-γ -lactone was weighed in a dry 5 mL round-bottom flask, 3 mL of dry tetrahydrofuran was added to dissolve it and slowly added dropwise to the reaction system. After the addition was completed, it was stirred at -78 ° C for 2 h and the reaction was monitored by TLC. After the reaction was completed, 16 mL of 1 M citric acid solution was added to quench the reaction, the temperature was raised to 0 ° C, the organic phase was separated, and the crude product was concentrated under reduced pressure, dissolved, and silica gel was added to stir the sample, and silica gel column chromatography was performed to obtain intermediate 9; The process of the cyanation reaction is as follows: the intermediate 9 is dissolved in a solvent and placed in a low temperature environment below -50°C, stirred for at least 20 minutes, then trifluoroacetic acid is added, stirred for 5 to 30 minutes, then trimethylsilyl trifluoromethanesulfonate is added dropwise, stirred for 10 to 60 minutes, then trimethylsilyl cyanide is added, and stirred for 1 to 5 hours; The process of the debenzylation reaction is as follows: the intermediate 10 is dissolved in a solvent and placed in a low temperature environment below -50°C, stirred for at least 20 minutes, and then boron trichloride is added dropwise, and the temperature is raised to -40 to -30°C, and stirred for 1 to 5 hours.

2. A method for synthesizing a 2-ethylbutyl((S)-(((2R,3R,4S,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-5-cyano)-4-fluoro-3-hydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alanine compound according to claim 1, characterized in that: The phosphorylation reaction process is as follows: the intermediate 11 is dissolved in a solvent and 2-ethylbutyl((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alanine is dissolved in a solvent, and the mixture is placed in an ice bath environment, dimethylaluminum chloride is slowly added dropwise, and the mixture is heated to room temperature and stirred for 5 to 10 days.